RFK Jr. and other Trump officials are backing psychedelics after the FDA rejected MDMA therapy. Now, Texas and federal ...

This new color is part of a bigger push to phase out artificial dyes, which have raised concerns in recent years.

The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...

Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to ...

Arcellx, Inc. advances anito-cel CAR-T therapy for relapsed/refractory multiple myeloma. Click for ACLX pivotal trials, FDA ...

On April 22, 2025, the U.S. Dept. of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) held a ...

According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...

One of the most important decisions many food start-ups will make is in which market to apply for novel food approval. What ...

The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.

Georgia's congressional delegation is advocating for FDA reconsideration of the drug elamipretide for Hope Filchak.

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...